Zachariah CohenZachariah Cohen
|
 |
Enbrel (for rheumatoid arthritis), Nasonex (nasal allergies) and Zelnorm (irritable bowel online pharmacy syndrome). "Throughout much of the early decade, it was growing at strong double-digit rates as pharmaceutical marketers hair loss medicine become more comfortable and experienced with DTC advertising," says Jon Swallen, TNS senior vice president of research. Sepracor's Lunesta, an insomnia drug known for its glowing moth icon, buy antidepressants online buy spent $75million on ads in the first online pharmacy quarter of 2008 vs. (c) 2008 USA TODAY, a division of Gannett Co. Pharmaceutical ad spending they count on to exceed $5 billion a year is losing on line pharmacy its potency. A service of YellowBrix, best pharmacy Inc.. Some major brands, such as Pfizer's Lipitor, have revamped ads under government pressingness. Two recent reports say drugmakers cut Rx ad spending in the first internet pharmacy six months of this year. Magazines and radio stations have seen the most drug ad decline. Among factors driving the drop, he says, are fewer drug launches, fear of government regulation and cuts by a few brands that had spent big. The site encourages consumers to keep an eye out for false rozerem or misleading ads and provides a jonah to report violators. The reports follow a well-publicized Harvard Medical School study that found consumer ads had little effect on prescription plan-b drug sales. Takeda Pharmaceuticals North America's Rozerem sleep aid, which used offbeat ad characters such as Jethro Kevin and a beaver, cut spending from $91million in the first half of 2007 to $15million in the first half this year. $175million in that quarter in 2007. That if the government gets involved, they'll be worse off." Last month, the Food and Item Administration stepped up its watch by asking consumers to help watch for disloyal or misleading drug ads. Rival ad tracker Nielsen Monitor-Plus calculates the decline at 4.8% to $2.7 billion. And it comes as they already are dealing with large spending declines in some other major ad categories, such as automotive and telecommunications, and recession fears, thanks to the crisis on Wall Street. Second-quarter spending in magazines fell 29% to $358million, according to TNS, while radio plummeted 62% to $4million. By Sophia Petrecca NEW YORK -- This could make media owners sick. Researchers focused on ads for three drugs. "The pharmaceutical companies perceive the threat of government regulation on marketing to be a stronger threat now than it has been in the past," and are trying to self-regulate, Swallen says. Results sho that direct-to-consumer (DTC) ads "probably aren't as effective as widely perceived," says Elbert Law, lead That bodes ill for the magazines, newspapers and radio and TV outlets for which the ads have been a prescription for profits. Those declines are an abrupt reversal from the robust spending growth of a few years ago. It launched a "Be Smart about Prescription Ware Advertising" area online at. TNS Media Intelligence puts the drop at 3.9% to $2.4 billion.
|